Home / Articles / Kidney Stones

Kidney Stones

Kidney Stones: What Science Now Knows About Causes, Prevention, and Treatment

Introduction: A Pain No One Forgets

Ask anyone who has passed a kidney stone and they’ll tell you: it’s an experience that stays with you. Often described as some of the most severe pain a person can feel, kidney stones — medically known as urolithiasis or nephrolithiasis — affect hundreds of millions of people worldwide and are becoming increasingly common. Yet despite their notoriety, most people know surprisingly little about why stones form, what puts certain individuals at heightened risk, or how modern medicine has transformed treatment beyond the painful waiting game of earlier decades.

Kidney stones are crystalline mineral deposits that form when certain substances in urine — calcium, oxalate, uric acid, and others — become concentrated enough to precipitate out of solution and solidify. They range in size from a grain of sand to a golf ball, and their behavior is equally variable: some pass silently, others cause excruciating obstruction. Understanding the biology behind stone formation, the factors that drive recurrence, and the expanding toolkit of treatment options is essential for anyone who has experienced a stone — or wants to avoid one.

Why Stones Form: The Basic Science

The Chemistry of Crystallization

The urinary tract is a dynamic chemical environment. The kidneys filter roughly 180 liters of blood per day, reclaiming the vast majority of water and dissolved minerals and excreting the rest as urine. Stone formation occurs when this balance tips: when the concentration of stone-forming minerals rises, when the volume of urine falls, or when the natural inhibitors of crystallization — citrate, magnesium, and certain proteins — are depleted.

The process has three stages. First, crystals nucleate — tiny mineral clusters form spontaneously when urine becomes supersaturated. Second, crystals grow by adding further mineral layers. Third, crystals aggregate into the macroscopic masses we call stones. For a stone to become clinically significant, it must also become lodged somewhere — typically in the narrow passages of the ureter — rather than washing freely into the bladder and out of the body.

Types of Kidney Stones

Not all kidney stones are the same, and distinguishing the type is clinically important because each has different causes and responds to different prevention strategies:

Stone Type Prevalence Key Cause Prevention Focus
Calcium oxalate ~70–80% of all stones High urinary oxalate, low citrate, low urine volume Hydration, dietary oxalate reduction, citrate supplementation
Calcium phosphate ~10–20% Alkaline urine pH, hyperparathyroidism Treat underlying cause; reduce sodium and animal protein intake
Uric acid ~5–10% Acidic urine pH, high purine diet, gout, insulin resistance Alkalinize urine, reduce purine intake, allopurinol in recurrent cases
Struvite (infection stones) ~5–15% Urease-producing bacterial infection Eradicate infection; surgical stone removal often required
Cystine ~1–2% Inherited cystinuria (genetic defect) High fluid intake, urinary alkalinization, D-penicillamine or tiopronin

Prevalence estimates reflect adult populations in high-income countries; distributions vary by geography, diet, and metabolic profile.

Who Gets Kidney Stones? Risk Factors Explained

Dietary Drivers

Diet is the most modifiable driver of stone risk, and its influence is substantial. The key dietary risk factors for the most common stone type — calcium oxalate — include:

  • Low fluid intake: Concentrated urine is the single biggest risk factor for stone formation. Individuals who consistently produce less than 2 liters of urine per day have significantly higher stone rates than those who are well-hydrated.
  • High dietary oxalate: Spinach, rhubarb, nuts, and certain grains are high in oxalate. In individuals with hyperoxaluria — excess urinary oxalate — dietary restriction can meaningfully reduce stone risk.
  • High sodium intake: Sodium raises urinary calcium excretion, increasing calcium supersaturation. Reducing dietary sodium is one of the most evidence-based dietary interventions for recurrent stone formers.
  • High animal protein: Increases urinary uric acid and reduces urinary citrate, creating conditions favorable to both uric acid and calcium oxalate stones.
  • Low dietary calcium: Counterintuitively, very low calcium diets can increase oxalate absorption from the gut, raising urinary oxalate. Current guidelines recommend normal dietary calcium intake rather than restriction for calcium stone formers.

Medical and Metabolic Risk Factors

Beyond diet, a range of underlying medical conditions substantially increase stone risk:

  • Primary hyperparathyroidism: Excess parathyroid hormone drives hypercalciuria and is found in a meaningful subset of recurrent stone formers.
  • Obesity and metabolic syndrome: Both are independently associated with uric acid stone formation through their effects on urinary pH and uric acid excretion.
  • Inflammatory bowel disease and malabsorptive conditions: Crohn’s disease, post-bariatric surgery states, and short bowel syndrome dramatically increase oxalate absorption, causing severe hyperoxaluria.
  • Gout: Uric acid overproduction leads to hyperuricosuria and persistently acidic urine — a direct pathway to uric acid stone disease.
  • Type 2 diabetes and insulin resistance: Associated with lower urinary pH, independently predicting uric acid stone risk even in patients without gout.
  • Recurrent urinary tract infections with urease-producing organisms (Proteus, Klebsiella, Pseudomonas): Drive struvite stone formation, which can fill the entire renal collecting system as staghorn calculi.

Genetics and Geography

Stone disease runs in families, and genetic factors explain a substantial fraction of its heritability. Beyond rare monogenic disorders like cystinuria and primary hyperoxaluria, common variants in genes regulating calcium and oxalate handling contribute to population-level variability in stone risk.

Geography plays an equally important role. The “stone belt” — a region of high stone prevalence spanning the southeastern United States, the Middle East, and South Asia — is characterized by hot climate, high ambient temperature, sweating, and dietary patterns that concentrate the urine and load it with stone-forming minerals. Globally, stone prevalence is rising, driven by dietary Westernization, obesity rates, and climate change effects on hydration patterns.

Diagnosis: From Colic to CT Scan

Recognizing a Kidney Stone

The classic presentation of renal colic is unmistakable: sudden, severe, colicky flank pain radiating to the groin, often accompanied by nausea, vomiting, and hematuria (blood in the urine). The pain follows the stone’s passage through the ureter — it typically begins in the flank as the stone exits the kidney and migrates toward the groin and genitalia as the stone descends.

Not all stones present this dramatically. Stones that remain stationary in the kidney may cause no symptoms at all, or only dull flank discomfort, until they move or grow large enough to obstruct urine flow.

Imaging Options

Modern stone diagnosis centers on imaging, and the options have evolved significantly:

  1. Non-contrast CT scan (NCCT): The gold standard for acute stone diagnosis — sensitivity and specificity both exceed 95%. Identifies stone location, size, and any associated hydronephrosis (kidney swelling due to obstruction). Provides essential information for treatment planning but carries radiation exposure.
  2. Ultrasound: First-line imaging in pregnancy and in children, where minimizing radiation is paramount. Less sensitive than CT for small ureteral stones but highly effective at detecting hydronephrosis and large renal stones.
  3. Plain abdominal X-ray (KUB): Useful for following calcium-containing stones during treatment (calcium stones are radiodense), but misses uric acid and other radiolucent stones. Limited utility as a primary diagnostic tool.
  4. Intravenous urogram (IVU): Largely superseded by CT but still used in some settings.

Stone composition can be partially inferred from CT density measurements (Hounsfield units) and location, but definitive analysis requires chemical analysis of a recovered stone — patients are strongly encouraged to strain their urine and save any passed stone for laboratory analysis.

Treatment: From Watchful Waiting to Laser Surgery

When Stones Pass on Their Own

The majority of small stones (less than 5–6 mm in diameter) will pass spontaneously without surgical intervention, given adequate hydration, analgesia, and time. Medical expulsive therapy — typically with an alpha-blocker such as tamsulosin — has been used to relax the ureteral smooth muscle and facilitate stone passage, though the evidence for its benefit in small stones remains mixed in the most recent systematic reviews.

When Intervention Is Needed

Larger stones, obstructing stones with signs of infection (a urological emergency), stones causing progressive renal impairment, or stones that fail to pass after a reasonable observation period all require active intervention. Modern urological stone treatment is largely minimally invasive:

  • Extracorporeal shock wave lithotripsy (ESWL): Uses focused shock waves to fragment stones from outside the body, allowing the fragments to pass in the urine. Ideal for smaller kidney and upper ureteral stones with favorable anatomy. Non-invasive but may require multiple sessions; less effective for hard stones (calcium oxalate monohydrate, cystine).
  • Ureteroscopy (URS) with laser lithotripsy: A thin flexible or semi-rigid scope is passed through the urethra and bladder into the ureter or kidney. The holmium:YAG laser then fragments the stone under direct vision, and fragments are retrieved with a basket. Has become the dominant treatment modality for most ureteral stones and many renal stones — high success rates, minimal recovery.
  • Percutaneous nephrolithotomy (PCNL): For large, complex, or staghorn calculi, a tract is created directly into the kidney through the skin. A nephroscope is passed through this tract for stone fragmentation and removal. Higher complication rate than URS but essential for stones that cannot be managed endoscopically.
  • Medical dissolution: Uric acid stones are uniquely amenable to medical dissolution — alkalinizing the urine with potassium citrate can dissolve uric acid stones over weeks to months without any invasive procedure.

Prevention: Breaking the Recurrence Cycle

Kidney stone disease recurs in approximately 50% of patients within 5–10 years of a first episode if no preventive measures are taken. Prevention is therefore as important as acute treatment — and far less dramatic.

The foundation of prevention is universal: increase urine output to at least 2–2.5 liters per day through adequate fluid intake. This single intervention reduces recurrence risk more than any other measure and applies to all stone types.

Beyond hydration, prevention is type-specific and ideally guided by a 24-hour urine metabolic evaluation, which identifies the specific abnormalities driving stone formation in an individual patient:

  • For calcium oxalate stones: dietary oxalate reduction, normal calcium intake, sodium restriction, and potassium citrate supplementation to raise urinary citrate.
  • For uric acid stones: alkalinization of urine with potassium citrate or bicarbonate, reduced purine intake, and allopurinol for hyperuricosuria.
  • For hypercalciuria unresponsive to dietary measures: thiazide diuretics reduce urinary calcium excretion and significantly cut recurrence risk.
  • For recurrent cystine stones: intensive hydration, urinary alkalinization, and cystine-binding medications.

Conclusion: Stone Disease Is Manageable — If You Take Action

Kidney stone disease has been transformed over the past three decades. What once required open surgery now requires a day procedure or none at all. What was once written off as bad luck is now understood as a condition with identifiable metabolic drivers and highly effective preventive strategies.

The key takeaways for anyone who has experienced a kidney stone — or wants to avoid one — are these: stay well hydrated every day; collect and analyze any stone that passes; pursue a 24-hour urine metabolic evaluation if you’ve had more than one stone; work with a urologist who specializes in stone disease to develop a personalized prevention plan; and don’t underestimate the power of dietary modification. Recurrence is not inevitable — it is, for most patients, preventable.

If you’re experiencing flank pain, hematuria, or have been told you have a kidney stone on imaging, see a urologist promptly. Untreated obstructing stones, particularly those accompanied by fever or chills, represent a urological emergency. Early intervention protects kidney function and prevents life-threatening complications. The science is on your side — use it.